An open label extension study of phase 3 clinical trial of duloxetine in patients with chronic low back pai
Phase 3
- Conditions
- Chronic low back pain
- Registration Number
- JPRN-jRCT2080222263
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Consecutive Participants:
Participants who have completed the 15-week treatment in the preceding study (A phase 3 clinical trial of duloxetine in patients with chronic low back pain)
New Participants:
Participants with chronic low back pain present on 6 months or longer.
And et al.
Exclusion Criteria
Participants having primary painful condition due to other than chronic low back pain.
And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method